Table 2 Confusion table of the cross-validation. Classification rates were estimated using a hold-out validation procedure to ensure applicability in routine laboratories.
From: Raman spectroscopy-based identification of toxoid vaccine products
True label [%] | T1 | T2 | dT1 | dT2 | dTaP | dTaP-IPV1 | dTaP-IPV2 | dT-IPV | IPV | DTaP-IPV-HepB | HepB | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Predicted vaccine label [%] | T1 | 100 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
T2 | 0 | 90 | 20 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
dT1 | 0 | 10 | 80 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
dT2 | 0 | 0 | 0 | 95 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
dTaP | 0 | 0 | 0 | 0 | 100 | 0 | 0 | 0 | 0 | 0 | 0 | |
dTaP-IPV1 | 0 | 0 | 0 | 0 | 0 | 100 | 0 | 0 | 0 | 0 | 0 | |
dTaP-IPV2 | 0 | 0 | 0 | 5 | 0 | 0 | 100 | 0 | 0 | 0 | 0 | |
dT-IPV | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 100 | 9 | 0 | 0 | |
IPV | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 91 | 0 | 0 | |
DTaP-IPV-HepB | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 100 | 0 | |
HepB | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 100 | |
Sensitivity [%] | 100 | 90 | 80 | 95 | 100 | 100 | 100 | 100 | 91 | 100 | 100 | |
Specificity [%] | 100 | 98 | 99 | 100 | 100 | 100 | 99 | 99 | 100 | 100 | 100 | |
Number of replicates | 10 | 10 | 10 | 21 | 10 | 11 | 11 | 10 | 11 | 10 | 10 | |
Number of averaged spectra | 100 | 100 | 100 | 210 | 100 | 110 | 110 | 100 | 110 | 100 | 100 | |
Number of original spectra | 1000 | 1000 | 1000 | 2100 | 1000 | 1100 | 1100 | 1000 | 1100 | 1000 | 1000 |
